Remimazolam versus propofol for general anaesthesia in children undergoing laparoscopic inguinal hernia repair: a propensity score- matched retrospective cohort study

Abstract Background Remimazolam is an ultra-short-acting benzodiazepine with a favourable safety profile, but comparative evidence against propofol in paediatric surgery remains limited. We compared remimazolam-based and propofol-based general anaesthesia in children undergoing laparoscopic inguinal hernia repair. Methods In this single-centre retrospective cohort study, children aged 3–12 years with American Society of Anesthesiologists physical status I–II who underwent elective laparoscopic inguinal hernia repair between April 2024 and May 2025 were identified from routinely collected clinical records. Children receiving remimazolam or propofol were matched 1:1 by nearest-neighbour propensity score matching with a 0.05 caliper. Emergence time was the primary outcome; secondary outcomes included airway-device removal time, intraoperative haemodynamic instability, adverse events within 24 h, postoperative recovery, length of stay and Pediatric Quality of Life Inventory 4.0 scores. Continuous and categorical variables were compared using appropriate parametric or non-parametric tests, chi-square or Fisher’s exact tests, and mixed-effects analysis for repeated quality-of-life measurements. Results After matching, 120 children were analysed in each group. Remimazolam was associated with shorter emergence time (median 11.5 vs 18.2 min) and airway-device removal time (13.2 vs 20.4 min; both P < 0.001), less intraoperative haemodynamic instability (15.0% vs 25.8%; P = 0.034), and fewer adverse events within 24 h (8.3% vs 35.8%; P < 0.001). Emergence agitation occurred in 3.3% versus 26.7%, and nausea or vomiting in 4.2% versus 18.3%. Oral intake, ambulation and hospital discharge occurred earlier in the remimazolam group. PedsQL scores were higher at 1 week and 1 month after surgery, with between-group differences exceeding the reported minimal clinically important difference. Conclusions In this propensity score-matched retrospective cohort of children undergoing laparoscopic inguinal hernia repair, remimazolam use was associated with shorter emergence and airway-device removal times and a lower observed incidence of selected postoperative adverse events than propofol. Higher postoperative PedsQL scores were also observed in the remimazolam group at follow-up. These findings should be interpreted cautiously because of the retrospective, single-centre design, the possibility of residual confounding, and limitations in the assessment of patient-reported outcomes. Prospective studies are needed to confirm these associations and evaluate their clinical significance.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11477276/v1
Primary Topic
Anesthesia and Sedative Agents
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Remimazolam versus propofol for general anaesthesia in children undergoing laparoscopic inguinal hernia repair: a propensity score- matched retrospective cohort study

李晓芳, Jun Liu, Junna Sun, Zhijie Jia et al.
Research Square
Anesthesia and Sedative Agents
preprint

Remimazolam versus propofol for general anaesthesia in children undergoing laparoscopic inguinal hernia repair: a propensity score- matched retrospective cohort study

李晓芳, Jun Liu, Junna Sun, Zhijie Jia, Jianmin Tian, Teng Fan
preprint en

Abstract

Abstract Background Remimazolam is an ultra-short-acting benzodiazepine with a favourable safety profile, but comparative evidence against propofol in paediatric surgery remains limited. We compared remimazolam-based and propofol-based general anaesthesia in children undergoing laparoscopic inguinal hernia repair. Methods In this single-centre retrospective cohort study, children aged 3–12 years with American Society of Anesthesiologists physical status I–II who underwent elective laparoscopic inguinal hernia repair between April 2024 and May 2025 were identified from routinely collected clinical records. Children receiving remimazolam or propofol were matched 1:1 by nearest-neighbour propensity score matching with a 0.05 caliper. Emergence time was the primary outcome; secondary outcomes included airway-device removal time, intraoperative haemodynamic instability, adverse events within 24 h, postoperative recovery, length of stay and Pediatric Quality of Life Inventory 4.0 scores. Continuous and categorical variables were compared using appropriate parametric or non-parametric tests, chi-square or Fisher’s exact tests, and mixed-effects analysis for repeated quality-of-life measurements. Results After matching, 120 children were analysed in each group. Remimazolam was associated with shorter emergence time (median 11.5 vs 18.2 min) and airway-device removal time (13.2 vs 20.4 min; both P < 0.001), less intraoperative haemodynamic instability (15.0% vs 25.8%; P = 0.034), and fewer adverse events within 24 h (8.3% vs 35.8%; P < 0.001). Emergence agitation occurred in 3.3% versus 26.7%, and nausea or vomiting in 4.2% versus 18.3%. Oral intake, ambulation and hospital discharge occurred earlier in the remimazolam group. PedsQL scores were higher at 1 week and 1 month after surgery, with between-group differences exceeding the reported minimal clinically important difference. Conclusions In this propensity score-matched retrospective cohort of children undergoing laparoscopic inguinal hernia repair, remimazolam use was associated with shorter emergence and airway-device removal times and a lower observed incidence of selected postoperative adverse events than propofol. Higher postoperative PedsQL scores were also observed in the remimazolam group at follow-up. These findings should be interpreted cautiously because of the retrospective, single-centre design, the possibility of residual confounding, and limitations in the assessment of patient-reported outcomes. Prospective studies are needed to confirm these associations and evaluate their clinical significance.

Research Square
Henan Medical University (CN)
Good health and well-being
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon